Literature DB >> 27371518

Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure.

Anthony J Choi1, Sunu S Thomas2, Jagmeet P Singh3.   

Abstract

Patients with advanced heart failure are at high risk for progression of their disease and sudden cardiac death. The role of device therapy in this patient population continues to evolve and is directed toward improving cardiac pump function and/or reducing sudden arrhythmic death.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmia; CIED; Cardiac resynchronization therapy; Defibrillator; Heart failure

Mesh:

Year:  2016        PMID: 27371518     DOI: 10.1016/j.hfc.2016.03.010

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  2 in total

1.  The safety and efficacy of cardiac contractility modulation in heart failure : A meta-analysis of clinical trials.

Authors:  X Liu; H J Yang; H Q Ping; S Qiu; S Shi; B Yang
Journal:  Herz       Date:  2017-01-18       Impact factor: 1.443

2.  Fusion cardiac resynchronization therapy in an left ventricular assist device patient from two devices and crossing leads: a case report.

Authors:  Anastasia D Egorova; Lieselot van Erven; Saskia L M A Beeres; Laurens F Tops
Journal:  Eur Heart J Case Rep       Date:  2021-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.